4//SEC Filing
Wei Lin 4
Accession 0001209191-23-006480
CIK 0001761918other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:53 AM ET
Size
8.7 KB
Accession
0001209191-23-006480
Insider Transaction Report
Form 4
Erasca, Inc.ERAS
Wei Lin
Chief Medical Officer
Transactions
- Other
Common Stock
2023-02-01$3.89/sh+2$8→ 315,812 total - Other
Common Stock
2023-02-01$4.10/sh+1,748$7,162→ 315,812 total - Award
Stock Option (right to buy)
2023-02-01+560,000→ 560,000 totalExercise: $4.00Exp: 2033-01-31→ Common Stock (560,000 underlying)
Footnotes (2)
- [F1]Includes 1,748 shares acquired under the Erasca, Inc. Employee Stock Purchase Plan (the ESPP) on June 15, 2022 and 2 shares acquired under the ESPP on December 15, 2022.
- [F2]1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Documents
Issuer
Erasca, Inc.
CIK 0001761918
Entity typeother
Related Parties
1- filerCIK 0001872772
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:53 AM ET
- Size
- 8.7 KB